Core Scientific (CORZ) is down today after announcing the pricing of a $3.3 billion offering of 7.750% senior secured notes due 2031 at 99.250% of par. The size of the secured issuance and the implied cost of capital are pressuring the stock as investors weigh the tradeoff between accelerating buildouts and layering on substantial fixed obligations. (investors.corescientific.com)

The notes are being sold in a private offering (Rule 144A/Reg S) and are expected to close on May 6, 2026, subject to customary conditions. Proceeds are earmarked for a debt service reserve account and a distribution up to the parent; Core Scientific plans to use a portion to repay outstanding delayed-draw term loans under its previously announced 364-day credit facility, plus accrued interest, fees, and expenses. (investors.corescientific.com)

Even when proceeds are tied to expansion, a very large secured bond deal can weigh on common stock because it increases senior claims on assets and introduces higher fixed charges, while also putting collateral and completion obligations at the center of the capital structure. Core Scientific also disclosed a completion guarantee related to certain datacenter development and construction projects, which can concentrate execution risk if builds run over budget or behind schedule. (investors.corescientific.com)

Key near-term catalysts are the May 6, 2026 closing of the note offering and any additional disclosures around project costs, schedules, and refinancing progress for the short-term facility. Investors will also focus on whether the company can translate project completion into higher high-density colocation revenue quickly enough to offset the added interest burden implied by the 7.750% coupon. (investors.corescientific.com)